These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5113402)

  • 1. Anticoagulant monitoring of volunteers using prothrombin activity tests with abnormal control plasmas: a cooperative study.
    Lorberbaum H
    Am J Clin Pathol; 1971 Oct; 56(4):487-92. PubMed ID: 5113402
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensity of oral anticoagulation, continued.
    N Engl J Med; 1983 Sep; 309(13):794-5. PubMed ID: 6888459
    [No Abstract]   [Full Text] [Related]  

  • 3. Standardization of anticoagulant control.
    Poller L
    Ric Clin Lab; 1978; 8(4):237-47. PubMed ID: 734318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of oral anticoagulant treatment.
    Br Med J; 1971 Nov; 4(5783):317-8. PubMed ID: 5124406
    [No Abstract]   [Full Text] [Related]  

  • 5. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. International Committee for Standardization in Haematology/International Committee on Thrombosis and Haemostasis.
    Blut; 1985 Mar; 50(3):185-7. PubMed ID: 3978243
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
    Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Thromb Haemost; 1985 Feb; 53(1):155-6. PubMed ID: 3992515
    [No Abstract]   [Full Text] [Related]  

  • 8. The prothrombin time and monitoring oral anticoagulant therapy.
    Brownell A; Mackie IJ; Machin SJ
    Br J Hosp Med; 1986 Dec; 36(6):442-3. PubMed ID: 3801752
    [No Abstract]   [Full Text] [Related]  

  • 9. [External quality control and standardization of prothrombin time determination for the monitoring of oral anticoagulant treatment in the Netherlands].
    van Duuk-Wierda CA; Loeliger EA; Roos J
    Ned Tijdschr Geneeskd; 1980 Jan; 124(4):103-7. PubMed ID: 7374832
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral anticoagulant drugs.
    Ansell JE
    N Engl J Med; 1992 Jan; 326(1):68; author reply 68-9. PubMed ID: 1727070
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral anticoagulant control.
    Lancet; 1987 Aug; 2(8557):488-9. PubMed ID: 2887782
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory monitoring of oral anticoagulant therapy: are we being misled?
    Albers GW
    Neurology; 1993 Mar; 43(3 Pt 1):468-70. PubMed ID: 8450985
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quality control of ISI/INR system in oral anticoagulant therapy].
    Kazama M
    Rinsho Ketsueki; 1990 Jun; 31(6):769-75. PubMed ID: 2214167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the control of oral anticoagulation.
    Loeliger EA
    Thromb Diath Haemorrh; 1972 Aug; 28(1):109-19. PubMed ID: 5074987
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapy.
    Jackson CM; Esnouf MP; Lindahl TL
    Pathophysiol Haemost Thromb; 2003; 33(1):43-51. PubMed ID: 12853712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False incoagulable PT-INR results in oral anticoagulant therapy.
    Redaelli R; Corno AR; Somaini MG; Gechtman C; Caimi TM; Baudo F; Morra E
    Thromb Res; 2008; 122(1):137-9. PubMed ID: 17996923
    [No Abstract]   [Full Text] [Related]  

  • 18. Rabbit (to replace human) brain material in anticoagulant control.
    Allington MJ; Bolton FG
    Lancet; 1986 May; 1(8489):1088. PubMed ID: 2871349
    [No Abstract]   [Full Text] [Related]  

  • 19. Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy.
    Pfäfflin A
    Clin Chem Lab Med; 2009; 47(2):242-3. PubMed ID: 19191733
    [No Abstract]   [Full Text] [Related]  

  • 20. Laboratory monitoring of oral anticoagulant therapy.
    Ginsberg JS; Hirsh J
    Hematol Pathol; 1989; 3(4):147-51. PubMed ID: 2697715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.